US Stock Market Closed

Dashboard

Wave Life Sciences Ltd. (WVE)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

CEO

Paul B. Bolno

Employees

301

Industry

Neurology Biopharmaceuticals

Sector

Healthcare

Headquarters

Singapore

Exchange

NASDAQ

Summary Stats

Market Cap

147M

Revenue

42.7M

Net Income

-118M

EPS

-$2.15

Price-to-Earnings

-1.12

Price-to-Book

18.8

Debt-to-Equity

20.4

News

Analyst Ratings

Price targets projected by 7 analysts

High

$27.00

Average

$16.57

Low

$7.00

Ratings calculated by 0 analysts

Buy

0

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Missed by -$0.07

Actual

-$0.62 -12.7%

Consensus

-0.55

Report Date

Year Ago

-0.86

Year Ago Change %

Up 27%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites